This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Ashok Bhandari, PhD
Executive Vice President, Chief Discovery Officer at Protagonist Therapeutics
Speaker

Profile

Dr. Bhandari has served as Executive Vice President & Chief Discovery Officer since January 2022 and has served as Senior Vice President and Vice President of Chemistry and Process Research from 2017 to 2021. Ashok joined Protagonist in 2011 as Director of Chemistry and focused on the discovery of novel peptide therapeutics leading to Protagonist's clinical pipeline. Prior to joining Protagonist, Dr. Bhandari worked at Affymax for 14 years, from 1994 to 2008, where he worked on a variety of peptide drug discovery, preclinical and clinical development programs on targets of protein-protein interactions. Dr. Bhandari received his Ph.D. in Organic Chemistry from the Indian Institute of Chemical Technology (IICT) and conducted his post-doctoral work also at the University of California, Santa Barbara.